For some time, we noticed a partial loss of potency in diluted preparations of tuberculin purified protein derivative (PPD) used in the intracutaneous method of skin testing. An attempt was made by Landi et al. (4) to determine the reason for this loss by replacing conventional PPD with '4C-labeled PPD and correlating the changes in biological activity and radioactivity in solution. By use of '4C-labeled PPD, this loss was shown to result mainly from the adsorption of the tuberculoprotein to glass or plastic surfaces. The present paper describes in detail the preparation of 4IC-labeled PPD and some of its properties.
MATERIALS AND METHODS
Source and isolation of crude 14C-tuberculin. The "Johnston" strain of Mycobacterium tuberculosis var. hominis, isolated in 1920 in Toronto, Canada, from a case of human tuberculosis, was used for the production of 14C-tuberculin PPD. The "Johnston" strain showed the characteristic surface growth of M. tuberculosis var. hominis on Long's synthetic medium (6), as well as virulence for guinea pigs and mice and nonvirulence for rabbits. The cultures of the organism were maintained by weekly subculture on Long's synthetic medium.
Long's medium was dispensed in 150-ml amounts into nine Roux bottles and autoclaved for 30 min at a steam pressure of 15 psi. These nine bottles were equally divided into three batches designated as batches 1 (Tables 1 to  3 ). The inoculum for the nine bottles was grown as a surface pellicle in a small Erlenmeyer flask on Long's synthetic medium at 37 C for 8 to 10 days. After inoculation, the Roux bottles were placed in a smaHl incubator at 37 C for 6 weeks. NaOH pellets were placed in a glass pan adjacent to the Roux bottles to remove expired 14CO2 during growth. The incubator was kept in a fume hood. After cultivation, the Roux bottles were tested for purity (2) and steamed for 3 hr in a flowing-steam unit (100 C). The bottles were allowed to stand overnight at room temperature. The contents of the bottles were then passed through a sterile flannelette cloth placed over a filter-paper pulp pad to separate the medium containing 14C-tuberculin from the bacterial growth. The filtrates of the three batches were kept in separate containers and designated "crude 14C-tuberculin solution," batches Tables 1 and 2 .
Radioactivity determinations. 14C-labeled material was assayed by evaporating portions of the liquid sample to dryness on stainless-steel planchets, which were then counted in a gas-flow Geiger Muller counter fitted with a Micromil window (Nuclear Chicago Corp., Des Plaines, 111.).
The radioactivity is recorded as indicated in the text, either in counts per minute per total amount of sample or as specific radioactivity in counts per minute per milligram of substance. No correction was made for the absorption of radioactivity by the buffer salts or by the bacterial cells.
Besides tuberculoprotein, tuberculin PPD contains various amounts of nucleic acid, depending upon the particular batch of tuberculin and on the method of precipitation. To determine the distribution of both weight and 14C between tuberculoprotein and nucleic acid, tuberculin PPD was separated by paper electrophoresis into the two groups of compounds (3).
The nucleic acid was extracted and assayed quantitatively by ultraviolet spectrophotometry. The difference in weight between the original tuberculin PPD and the nucleic acid was taken as the weight of the tuberculoprotein. The distribution of 14C was determined by autoradiography (1) and direct counting of the excised radioactive portion of the paper strips. From these data and the specific radioactivities of the tuberculin PPD preparations, the specific radioactivities of tuberculoprotein and nucleic acid were calculated.
Tuberculin skin tests in guinea pigs. Comparisons of the potency of 14C-tuberculin PPD, batches 1, 2, and 3, were made with National Institutes of Health (NIH) reference standard tuberculin PPD, lot 69. A 4-mg sample of each batch was dissolved in 4 ml of 0.016 M Na2HPO4. These solutions, as well as the standard, were further diluted in phosphate-buffered saline containing 0.3% phenol and 0.0005% Tween 80 to give concentrations of 0.002 mg/ml and 0.0005 mg/ml. Doses of 0.1 ml of each concentration for batches 1, 2, and 3 and the standard PPD were injected intradermally into a total of 48 BCG-sensitized a Procedure used corresponded to method B previously described by Landi and Held (3).
bInitial radioactivity in culture medium was 444 X 106 counts per min. The added radioactivity in microcuries was approximately 600, c.
c Saturated solution of (NH4)2SO4 (room temperature), previously adjusted to pH 7.2 with K2HPO4, was added to the "4C-tuberculin PPD stock solutions (5 C).
d Washing was by stirring up the precipitates with a glass rod and centrifuging again.
e The precipitate was ground in a mortar and vacuum-dried over CaCl2 . female guinea pigs. At 24 hr after injection, the size of each reaction was recorded as the sum of two perpendicular diameters in millimeters. The estimate of potency was made by the method of Long, Miles, and Perry (5).
RESULTS AND DIscussIoN
Recovery of radioactivity. The recovery of 14C in tuberculin PPD in method D was greater when glutamic acid was replaced with a mixture of amino acids as 14C source (Table 3) . Similar trends were found in the total 14C content of the bacterial cells. After removal of the bulk of nucleic acid by method B (Table 3) , the per cent recovery of 14C in the final product was still higher with the amino acid mixture than with L-glutamic acid as 14C source.
The differences between batches 1 and 2 in the radioactivity of cells and tuberculin PPD, and in the amount of 14C unaccounted for (approximately 82% in batch 1 and approximately 59% in batch 2) show that the amount of 4IC incorporated into tuberculoprotein was larger in batch 2 than in batch 1. Therefore, to favor the production of 14C-labeled tuberculin PPD with a higher specific radioactivity, it is preferable to use a mixture of radioactive amino acids as represented by the 14C-Chlorella protein hydrolysate, rather than the highly metabolizing amino acid, glutamic acid, labeled with "C. The radioactivity unaccounted for was lost during the growth and steaming process.
Distribution of radioactivity between tuberculoprotein and nucleic acid in "C-tuberculin PPD. Table 4 shows the distribution of weight and radioactivity between tuberculoprotein and nucleic acid in the three batches of tuberculin PPD. In batches 1 and 2, the nucleic acid comprised 27 to 37% of the total weight, but contained only 16 to 18% of the total radioactivity. In method B, most of the nucleic acid remained in the supernatant fluid after (NH4) 2S04 precipitation. The nucleic acid of batch 3, therefore, comprised only 4.5% of the total weight and 1.8% of the total "IC. The data show that the "IC-content relative to weight (specific radioactivity) was considerably higher in the tuberculoprotein than in the nucleic acid.
Biological activity of "4C-tuberculin PPD. Skin tests on 48 BCG-sensitized guinea pigs used to compare the three batches of "4C-tuberculin PPD with the NIH reference standard PPD showed that the relative potency of batches 1 and 2 was 50 to 60% compared with the standard, whereas batch 3 showed the same relative potency as the standard (Table 5) . However, the recovery of potency in tuberculin units was higher for the trichloroacetic acid precipitates (batches 1 and 2) than for the ammonium sulfate precipitate (batch 3; Table 5 ). The results are in agreement with our previous work with nonlabeled tuberculin PPD (3) , and show that the skin test is not affected by the low level of 14C of the tuberculin PPD used in these studies.
Use of radioactive tuberculin. 14C-tuberculin PPD has been used to measure the adsorption of tuberculoprotein to glass and other surfaces (4 '4C-tuberculin PPD should prove helpful in the study of the mechanism of the tuberculin skin reaction, in the elucidation of the structure of tuberculoprotein, in the evaluation of the efficacy of antiadsorption agents, and in the study of interactions between tuberculoprotein and other ingredients in PPD solutions. 
